BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 31390219)

  • 1. Identification of Hub Genes in Duchenne Muscular Dystrophy: Evidence from Bioinformatic Analysis.
    Zhang R; Lv L; Ban W; Dang X; Zhang C
    J Comput Biol; 2020 Jan; 27(1):1-8. PubMed ID: 31390219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying the hub genes for Duchenne muscular dystrophy and Becker muscular dystrophy by weighted correlation network analysis.
    Wang J; Fan Q; Yu T; Zhang Y
    BMC Genom Data; 2021 Dec; 22(1):57. PubMed ID: 34922439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of hub genes, miRNAs and regulatory factors relevant for Duchenne muscular dystrophy by bioinformatics analysis.
    Xiu MX; Zeng B; Kuang BH
    Int J Neurosci; 2022 Mar; 132(3):296-305. PubMed ID: 32791870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying hub genes and dysregulated pathways in Duchenne muscular dystrophy.
    Xin J; Liu S
    Int J Neurosci; 2024 Jan; ():1-13. PubMed ID: 38179963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening and identification of key biomarkers in hepatocellular carcinoma: Evidence from bioinformatic analysis.
    Li L; Lei Q; Zhang S; Kong L; Qin B
    Oncol Rep; 2017 Nov; 38(5):2607-2618. PubMed ID: 28901457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of pivotal genes and pathways in the synovial tissue of patients with rheumatoid arthritis and osteoarthritis through integrated bioinformatic analysis.
    Aihaiti Y; Tuerhong X; Ye JT; Ren XY; Xu P
    Mol Med Rep; 2020 Oct; 22(4):3513-3524. PubMed ID: 32945465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microarray gene expression profiling and bioinformatics analysis reveal key differentially expressed genes in clival and sacral chordoma cell lines.
    Li G; Cai L; Zhou L
    Neurol Res; 2019 Jun; 41(6):554-561. PubMed ID: 30821656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of lung adenocarcinoma biomarkers based on bioinformatic analysis and human samples.
    Dong S; Men W; Yang S; Xu S
    Oncol Rep; 2020 May; 43(5):1437-1450. PubMed ID: 32323809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Key Biomarkers and Potential Molecular Mechanisms in Oral Squamous Cell Carcinoma by Bioinformatics Analysis.
    Yang B; Dong K; Guo P; Guo P; Jie G; Zhang G; Li T
    J Comput Biol; 2020 Jan; 27(1):40-54. PubMed ID: 31424263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-X-C motif chemokine ligand 12: a potential therapeutic target in Duchenne muscular dystrophy.
    Lai X; Chen J
    Bioengineered; 2021 Dec; 12(1):5428-5439. PubMed ID: 34424816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of potential biomarkers of gout through competitive endogenous RNA network analysis.
    Li Y; Huang C; Yang Z; Wang L; Luo D; Qi L; Li Z; Huang Y
    Eur J Pharm Sci; 2022 Jun; 173():106180. PubMed ID: 35378210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening and identification of hub genes in pancreatic cancer by integrated bioinformatics analysis.
    Chen Q; Yu D; Zhao Y; Qiu J; Xie Y; Tao M
    J Cell Biochem; 2019 Dec; 120(12):19496-19508. PubMed ID: 31297881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Potential Hub Genes and Therapeutic Drugs in Malignant Pleural Mesothelioma by Integrated Bioinformatics Analysis.
    Zhang X; Yang L; Chen W; Kong M
    Oncol Res Treat; 2020; 43(12):656-671. PubMed ID: 33032291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Hub Genes and Key Pathways Associated with Peripheral T-cell Lymphoma.
    Gao HX; Wang MB; Li SJ; Niu J; Xue J; Li J; Li XX
    Curr Med Sci; 2020 Oct; 40(5):885-899. PubMed ID: 32980897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis.
    Li F; Guo P; Dong K; Guo P; Wang H; Lv X
    J Comput Biol; 2019 Nov; 26(11):1278-1295. PubMed ID: 31233342
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of hub genes and regulators associated with pancreatic ductal adenocarcinoma based on integrated gene expression profile analysis.
    Shang M; Zhang L; Chen X; Zheng S
    Discov Med; 2019 Sep; 28(153):159-172. PubMed ID: 31926587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA methylation biomarkers for nasopharyngeal carcinoma.
    Han B; Yang X; Zhang P; Zhang Y; Tu Y; He Z; Li Y; Yuan J; Dong Y; Hosseini DK; Zhou T; Sun H
    PLoS One; 2020; 15(4):e0230524. PubMed ID: 32271791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of six candidate genes for endometrial carcinoma by bioinformatics analysis.
    Zhu Y; Shi L; Chen P; Zhang Y; Zhu T
    World J Surg Oncol; 2020 Jul; 18(1):161. PubMed ID: 32641130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.